Elevated Fibrinogen and Unique Complement Signatures- A Proteomic Biomarker Panel for Myasthenia Gravis

Real-world Treatment Patterns, Discontinuation, and Treatment Switches in Patients With Generalized Myasthenia Gravis (gMG): A Retrospective Claims Analysis

Unmet Needs Amongst Patients With Generalized Myasthenia Gravis in the U.S.: A Descriptive Comparison Across Two Time Periods Using the MGFA Global MG Patient Registry